Valtorcitabine

Known as: 3'-VAL-L-DC, L-Valine, 3'-Ester with 2'-Deoxycytidine 
An orally active prodrug of torcitabine (L-deoxycytidine), a nucleoside analog with activity against hepatitis B virus. Torcitabine is modified in… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2017
0120042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
OBJECTIVE The review covers basic principles of the prodrug strategy applied to antiviral nucleoside drugs or drug candidates… (More)
Is this relevant?
Review
2007
Review
2007
Conventional treatment of chronic hepatitis B with interferon alfa-2b, lamivudine, and adefovir is limited by low rates of… (More)
Is this relevant?
Review
2005
Review
2005
Currently approved treatments for chronic infection with hepatitis B virus (HBV) are limited by low rates of sustained response… (More)
Is this relevant?
Review
2004
Review
2004
Idenix (formerly Novirio) and Novartis are developing two beta-L-deoxynucleosides, telbivudine and torcitabine, for the potential… (More)
Is this relevant?